Rare Diseases and Orphan Drugs

Rare Diseases in Oncology

Rare cancers and diseases still cancers that will be predominant in medically underserved populations. In several cases, the data CCR’s investigators gain from learning and treating rare cancers and connected diseases provides them with insights into the mechanisms that underlie different additional common malignancies. Rare cancers and rare diseases are to deal with challenges and propose solutions to eliminate the hurdles with those patients suffering with rare cancers, researchers, medical professionals. it's meant that the in-depth, knowledge base dialogue of this skilled working party can formulate AN rising agreement on an operating definition of symptom clusters and, specific gaps and opportunities that give a foundation for a transformative strategic blueprint to guide future symptom cluster analysis in rare cancers.